Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Novartis Ag
Relationship:   10% Owner
City:   Basel Switzerland
State:   V8
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   49,437,478    

Indirect Shares

   22,159,174      
Direct Value   $497,714,530    

Indirect Value

   $329,257,732      
Total Shares   71,596,652      
Total Value   $826,972,262      


Adhera Therapeutics, Inc $0 Eledon Pharmaceuticals Ord Shs $11,256,112 Kineta Ord Shs $896,047 Aeglea Biotherapeutics, Inc. $1,306,711 Intellia Therapeutics, Inc. $108,286,057 Q32 Bio Inc $58,189,244 Ra Pharmaceuticals, Inc. $105,728,421 Surface Oncology, Inc. $4,224,876 Aileron Therapeutics Inc $8,109,637 Bicycle Therapeutics Ltd $0 Galera Therapeutics, Inc. $468,913 Poseida Therapeutics, Inc. $20,441,988 Cellular Biomedicine Group Inc $28,800,576 Precision Biosciences Inc $150,005,950 Adhera Therapeutics, Inc $0 Eledon Pharmaceuticals Ord Shs $11,256,112 Kineta Ord Shs $896,047 Aeglea Biotherapeutics, Inc. $1,306,711 Intellia Therapeutics, Inc. $108,286,057 Q32 Bio Inc $58,189,244 Ra Pharmaceuticals, Inc. $105,728,421 Surface Oncology, Inc. $4,224,876 Aileron Therapeutics Inc $8,109,637 Bicycle Therapeutics Ltd $0 Galera Therapeutics, Inc. $468,913 Poseida Therapeutics, Inc. $20,441,988 Cellular Biomedicine Group Inc $28,800,576 Precision Biosciences Inc $150,005,950
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    14    

     Stock price went up :
    0   
    14    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   14.0   
     Percentage Gain/Loss :
     0.0%
 273.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Momenta Pharmaceuticals Inc MNTA 10% Owner 0 2006-07-25 4,708,679    Premium*  
            Adhera Therapeutics, Inc ATRX 10% Owner 2011-01-26 2,495,065 0    Premium*  
            Idenix Pharmaceuticals Inc IDIX 10% Owner 2014-08-05 0 2014-08-05 0    Premium*  
            Eledon Pharmaceuticals Ord Shs ELDN 10% Owner 2015-07-15 4,493,458 2014-09-22 0    Premium*  
            Kineta Ord Shs KA 10% Owner 2016-02-17 1,873,791 2016-02-17 0    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE 2018-05-11 2,175,314 2016-04-12 0    Premium*  
            Intellia Therapeutics, Inc. NTLA 10% Owner 2017-12-12 4,129,903 2016-05-11 0    Premium*  
            Q32 Bio Inc QTTB 10% Owner 2018-04-02 1,979,226 2018-04-02 0    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2017-06-19 2,251,457 2016-10-31 0    Premium*  
            Aadi Bioscience, Inc AADI 10% Owner 2017-03-15 0 2019-04-26 4,049,804    Premium*  
            Altimmune, Inc ALT 10% Owner 0 2018-09-12 8,345,145    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 3,948,482 2018-04-23 0    Premium*  
            Aileron Therapeutics Inc ALRN 10% Owner 2019-04-01 2,079,394 2018-07-16 0    Premium*  
            Bicycle Therapeutics Ltd BCYC 10% Owner 2019-05-28 1,769,641 2019-05-28 0    Premium*  
            Galera Therapeutics, Inc. GRTX Former 10% Owner 2020-06-19 2,467,961 2019-11-12 3,543,067    Premium*  
            Forma Therapeutics Holdings, Inc., FMTX 10% Owner 0 2020-06-18 331,221    Premium*  
            Akouos, Inc. AKUS Former 10% Owner 2020-06-30 0 2020-06-30 1,181,258    Premium*  
            Poseida Therapeutics, Inc. PSTX 10% Owner 2020-07-14 5,908,089 2020-07-14 0    Premium*  
            Cellular Biomedicine Group Inc CBMG 10% Owner 2020-08-11 1,458,257 0    Premium*  
            Precision Biosciences Inc DTIL 10% Owner 2022-06-15 12,407,440 0    Premium*  
* Premium Members only  

Records found :    152         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
IDIX Idenix Pharmaceuticals In... 10% Owner   –       –       •   2014-08-05 4 D $24.50 $816,356,513 D/D (33,320,674) 0 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2016-10-31 4 S $13.00 $4,407 D/D (339) 62,575 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2016-10-31 4 OE $0.07 $4,404 D/D 62,914 62,914 0 -
FMTX Forma Therapeutics Holdin... 10% Owner   –       –       •   2020-06-18 3 IO $0.00 $0 I/I 0 331,221 -
BCYC Bicycle Therapeutics Ltd 10% Owner   –       –       •   2019-05-28 4 OE $0.00 $0 D/D 71,450 964,645 0 -
AKUS Akouos, Inc. Former 10% Owner   –       –      –    2020-06-30 4 A $0.00 $0 I/I 1,056,258 1,056,258 0 -
AKUS Akouos, Inc. Former 10% Owner   –       –      –    2020-06-30 4 B $17.00 $2,125,000 I/I 125,000 1,181,258 0.01 -
CBMG Cellular Biomedicine Grou... 10% Owner   –       –       •   2020-08-11 3 IO $0.00 $0 D/D 0 1,458,257 %
KA Kineta Ord Shs 10% Owner   –       –       •   2016-02-17 4 A $0.00 $0 D/D 1,498,791 1,498,791 0 -
BCYC Bicycle Therapeutics Ltd 10% Owner   –       –       •   2019-05-28 4 A $0.00 $0 D/D 1,529,561 1,601,011 0 -
BCYC Bicycle Therapeutics Ltd 10% Owner   –       –       •   2019-05-28 4 B $14.00 $2,360,820 D/D 168,630 1,769,641 2.45 -
ALT Altimmune, Inc 10% Owner   –       –       •   2017-05-04 3 IO $0.00 $0 I/I 0 1,867,301 -
KA Kineta Ord Shs 10% Owner   –       –       •   2016-02-17 4 B $8.00 $3,000,000 D/D 375,000 1,873,791 2.45 -
QTTB Q32 Bio Inc 10% Owner   –       –       •   2018-04-02 4 A $0.00 $0 D/D 1,979,226 1,979,226 0 -
AGLE Aeglea Biotherapeutics, I... 10% Owner   –       –       •   2016-04-12 4 A $0.00 $0 D/D 2,010,924 2,010,924 0 -
ALT Altimmune, Inc 10% Owner   –       –       •   2017-11-14 4 A $0.00 $0 I/I 182,262 2,049,563 0 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2019-04-01 4 S $1.90 $39,159 D/D (20,610) 2,079,394 0 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2019-03-29 4 S $1.85 $197,099 D/D (106,540) 2,100,004 0 -
AGLE Aeglea Biotherapeutics, I...   •       •       •   2018-05-11 4 S $10.06 $196,673 D/D (19,550) 2,175,314 0 -
AGLE Aeglea Biotherapeutics, I...   •       •       •   2018-05-10 4 S $10.13 $230,204 D/D (22,725) 2,194,864 0 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2019-03-15 4 S $1.92 $84,096 D/D (43,800) 2,206,544 0 -
AGLE Aeglea Biotherapeutics, I...   •       •       •   2018-05-09 4 S $10.11 $517,935 D/D (51,230) 2,217,589 0 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2019-03-14 4 S $1.88 $25,944 D/D (13,800) 2,250,344 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-06-19 4 S $22.02 $70,899 D/D (3,220) 2,251,457 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-06-16 4 S $21.24 $1,130,207 D/D (53,200) 2,254,677 0 -
  152  Records found
  1  2   3   4   5   6   7      
  Page 1 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us